The Vanguard Group 13D and 13G filings for Zynerba Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-02-10 12:04 pm Sale |
2020-12-31 | 13G | Zynerba Pharmaceuticals, Inc. ZYNE |
The Vanguard Group | 1,035,402 3.520% |
-638,560 (-38.15%) |
Filing |